Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Race Oncology Ltd
RAONFCurrent price
1.22 USD
0 USD (0.00%)
Last closed
1.68 AUD
Company
www.raceoncology.com
ISIN
AU000000RAC3
Sector
Healthcare
Industry
Biotechnology
Exchange
AU
Capitalization
275 774 336 AUD
Yield for 12 month
+83.15 %
1Y
3Y
5Y
10Y
15Y
RAONF
Race Oncology Limited, a clinical stage biopharmaceutical company, focuses on cancer care. Its lead product is bisantrene, a small molecule chemotherapeutic. The company is developing bisantrene to address the unmet need of patients across multiple oncology indications; delivers cardioprotection; and improves anti-cancer activity in solid tumors. It is also investigating the impact bisantrene and new molecules have on the m6A RNA pathway, following independent research describing bisantrene as the potent inhibitor of fat mass and obesity-associated protein (FTO). The company is in collaboration with City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong, and University of Newcastle. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia. Address: Gateway, 1 Macquarie Place, Sydney, NSW, Australia, 2000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
–
Last Year
+3 092 888 AUD
Current Quarter
–
Last Quarter
+3 950 472 AUD
Current Year
-277 473 AUD
Last Year
+2 815 415 AUD
Current Quarter
-138 736 AUD
Last Quarter
+3 811 735 AUD
Key Figures RAONF
1 year
3 years
5 years
10 years
EBITDA
-14 015 350 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-38.63 %
PEG Ratio
–
Return On Equity TTM
-63.1 %
Wall Street Target Price
–
Revenue TTM
3 950 472 AUD
Book Value
0.11 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
1 093 240 AUD
Earnings per share
-0.079 AUD
Diluted Eps TTM
-0.079 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RAONF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RAONF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation RAONF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
69.808
Enterprise Value EBITDA
-21.5133
Price Book MRQ
15.4478
Financials RAONF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RAONF
For 52 weeks
0.63 AUD
2.06 AUD
50 Day MA
1.62 AUD
Shares Short Prior Month
–
200 Day MA
1.28 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart